Sign In
Buy EVH
$3.78
-0.180 (-4.55%)
At Close: Jun 03, 2026
Evolent Health, Inc. Just Released Its Full-Year Earnings: Here’s What Analysts Think
06:58pm, Thursday, 27'th Feb 2020
There's been a notable change in appetite for Evolent Health, Inc. (NYSE:EVH) shares in the week since its yearly...
Teladoc (TDOC) Receives a Hold from Cantor Fitzgerald
01:50pm, Thursday, 27'th Feb 2020
In a report released today, Steven Halper from Cantor Fitzgerald reiterated a Hold rating on Teladoc (TDOC), with a price target of $135.00. The company's
Teladoc (TDOC) Receives a Hold from Cantor Fitzgerald
01:50pm, Thursday, 27'th Feb 2020
In a report released today, Steven Halper from Cantor Fitzgerald reiterated a Hold rating on Teladoc (TDOC – Research Report),
Canaccord Genuity Sticks to Its Hold Rating for Castlight Health (CSLT)
11:49am, Thursday, 27'th Feb 2020
In a report released yesterday, Richard Close from Canaccord Genuity maintained a Hold rating on Castlight Health (CSLT), with a price target of $1.50.
Canaccord Genuity Sticks to Its Hold Rating for Castlight Health (CSLT)
11:49am, Thursday, 27'th Feb 2020
In a report released yesterday,
Richard Close
from Canaccord Genuity maintained a
Hold
rating on Castlight Health (
CSLT
–
Research Report
), with a price target of
$1.50
. The company’s shares cl
Canaccord Genuity Reaffirms Their Buy Rating on Teladoc (TDOC)
11:43am, Thursday, 27'th Feb 2020
In a report released yesterday, Richard Close from Canaccord Genuity maintained a Buy rating on Teladoc (TDOC), with a price target of $130.00. The
Evolent Health Inc (EVH) Q4 2019 Earnings Call Transcript
04:00pm, Wednesday, 26'th Feb 2020
EVH earnings call for the period ending December 31, 2019.
Evolent Health to Participate in Upcoming Investor Conferences
04:00pm, Wednesday, 26'th Feb 2020
Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Executive Officer and
Cantor Fitzgerald Reiterates Their Buy Rating on Evolent Health (EVH)
12:20pm, Wednesday, 26'th Feb 2020
Cantor Fitzgerald analyst Steven Halper reiterated a Buy rating on Evolent Health (EVH) today and set a price target of $14.00. The company's shares
Analysts Offer Insights on Technology Companies: CoStar Group (CSGP) and Castlight Health (CSLT)
12:19pm, Wednesday, 26'th Feb 2020
Companies in the Technology sector have received a lot of coverage today as analysts weigh in on CoStar Group (CSGP) and Castlight Health (CSLT). CoStar
Canaccord Genuity Sticks to Its Buy Rating for Evolent Health (EVH)
11:24am, Wednesday, 26'th Feb 2020
In a report released yesterday, Richard Close from Canaccord Genuity reiterated a Buy rating on Evolent Health (EVH), with a price target of $17.00. The
Canaccord Genuity Sticks to Its Buy Rating for Evolent Health (EVH)
11:24am, Wednesday, 26'th Feb 2020
In a report released yesterday, Richard Close from Canaccord Genuity reiterated a Buy rating on Evolent Health (EVH – Research
Evolent Health price target raised to $17 from $10.15 at Piper Sandler EVH
10:07am, Wednesday, 26'th Feb 2020
Evolent Health price target raised to $17 from $10.15 at Piper Sandler Piper Sandler EVH
Edited Transcript of EVH earnings conference call or presentation 25-Feb-20 10:00pm GMT
08:41am, Wednesday, 26'th Feb 2020
Q4 2019 Evolent Health Inc Earnings Call
Evolent Health's (EVH) CEO Frank Williams on Q4 2019 Results - Earnings Call Transcript
05:16am, Wednesday, 26'th Feb 2020
Evolent Health, Inc. (NYSE:EVH) Q4 2019 Earnings Conference Call February 25, 2020 05:00 PM ET Company Participants Frank Williams - CEO John Johnson - CFO Seth
